The Ofichem Group manufactures, develops and distributes active pharmaceutical ingredients (APIs) for both the veterinary and human market. These active compounds are distributed worldwide to pharmaceutical producers. The production of APIs is in accordance with the guidelines of Good Manufacturing Practices (GMP). The Ofichem Group also has his own laboratory which doesn't only analyse the produced APIs, but also analyses APIs for external clients.